VENA, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 11.446
AS - Asia 2.245
NA - Nord America 1.126
SA - Sud America 200
AF - Africa 47
OC - Oceania 7
Totale 15.071
Nazione #
IT - Italia 11.074
US - Stati Uniti d'America 1.069
SG - Singapore 882
CN - Cina 572
VN - Vietnam 476
FR - Francia 142
BR - Brasile 120
HK - Hong Kong 76
DE - Germania 50
FI - Finlandia 34
BD - Bangladesh 30
AR - Argentina 29
IN - India 29
IQ - Iraq 28
JP - Giappone 27
GB - Regno Unito 26
NL - Olanda 25
CA - Canada 22
ID - Indonesia 21
MX - Messico 20
ZA - Sudafrica 14
EC - Ecuador 13
ES - Italia 13
VE - Venezuela 13
PH - Filippine 11
TH - Thailandia 11
PK - Pakistan 10
UZ - Uzbekistan 10
TR - Turchia 9
CO - Colombia 8
RU - Federazione Russa 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
JO - Giordania 7
PT - Portogallo 7
PY - Paraguay 7
UA - Ucraina 7
TW - Taiwan 6
AT - Austria 5
AU - Australia 5
DZ - Algeria 5
EG - Egitto 5
NP - Nepal 5
RO - Romania 5
SE - Svezia 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
IE - Irlanda 4
KR - Corea 4
MA - Marocco 4
MY - Malesia 4
PL - Polonia 4
SA - Arabia Saudita 4
BO - Bolivia 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
LB - Libano 3
MT - Malta 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
MK - Macedonia 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
KE - Kenya 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
NZ - Nuova Zelanda 1
PA - Panama 1
PF - Polinesia Francese 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 15.071
Città #
Genoa 6.006
Genova 2.105
Vado Ligure 1.451
Rapallo 1.199
Singapore 404
San Jose 382
Ashburn 204
Ho Chi Minh City 157
Lauterbourg 127
Hanoi 106
Council Bluffs 80
New York 79
Bordighera 77
Beijing 76
Hong Kong 74
Frankfurt am Main 38
Santa Clara 34
Helsinki 28
Rome 25
Haiphong 24
Milan 24
Tokyo 24
Da Nang 21
Los Angeles 20
Tianjin 17
Biên Hòa 14
Chicago 12
London 12
Baghdad 11
Orem 11
Amsterdam 10
St Louis 10
São Paulo 10
Tashkent 10
Can Tho 9
Madrid 9
Toronto 9
Amman 7
Hải Dương 7
Johannesburg 7
Montreal 7
Naples 7
Quito 7
Curitiba 6
Guangzhou 6
Mexico City 6
Turin 6
Zurich 6
Bangkok 5
Bologna 5
Bra 5
Caracas 5
City of London 5
Erbil 5
Jakarta 5
Kyiv 5
Lisbon 5
Stockholm 5
Suzhou 5
Sydney 5
Thái Nguyên 5
Verona 5
Atlanta 4
Buffalo 4
Bắc Giang 4
Bắc Ninh 4
Charlotte 4
Chennai 4
Denver 4
Dubai 4
Dublin 4
Houston 4
Istanbul 4
Jersey City 4
Lahore 4
Lappeenranta 4
Modena 4
Nha Trang 4
Paris 4
Porto Alegre 4
Quảng Ngãi 4
Rio de Janeiro 4
Shanghai 4
Warsaw 4
Acalanes Ridge 3
Addis Ababa 3
Asunción 3
Buenos Aires 3
Catania 3
Dallas 3
Florence 3
Guayaquil 3
Hyderabad 3
Islington 3
Jeddah 3
Marseille 3
Nam Định 3
Pasadena 3
Piscataway 3
Prague 3
Totale 13.187
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 213
Mould Infections of Traumatic Wounds: A Brief Narrative Review 212
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 191
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 190
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 187
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 180
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 173
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 171
Bloodstream infections in critically ill patients with COVID-19 171
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 168
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 163
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 160
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 158
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 154
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 152
Treatment of Infections Due to MDR Gram-Negative Bacteria 149
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 148
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 146
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 133
Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain 131
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 130
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 128
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 127
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 125
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 121
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 120
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 119
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 119
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 115
Characterization of T lymphocytes in severe COVID-19 patients 115
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 112
Antibiotic treatment of acute bacterial skin and skin structure infections 112
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 111
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 110
Tracheostomy Timing and Outcome in Severe COVID-19: The WeanTrach Multicenter Study 108
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 108
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 105
The role of new β-lactamase inhibitors in gram-negative infections 105
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 104
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 104
Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients 102
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 101
Adequate duration of therapy in severe fungal infections 100
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians? 100
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 100
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 99
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 98
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 98
Diagnosis and Treatment of Candidemia in the Intensive Care Unit 98
Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies 97
Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients 96
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 96
Antiviral treatment selection for SARS-CoV-2 pneumonia 96
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 94
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 93
Are incidence and epidemiology of anaerobic bacteremia really changing? 92
Frequency of Detection of Candida auris Colonization Outside a Highly Endemic Setting: What Is the Optimal Strategy for Screening of Carriage? 92
Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review 92
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 92
The Role of Dysbiosis in Critically Ill Patients With COVID-19 and Acute Respiratory Distress Syndrome 91
Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit 88
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 87
Mortality of Pneumocystis jirovecii pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG 86
Molecular epidemiological investigation of a nosocomial cluster of c. Auris: Evidence of recent emergence in italy and ease of transmission during the covid‐19 pandemic 86
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 86
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 85
The multifaceted presentation of syphilitic chorioretinitis examined by multimodal imaging: A case series 85
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 84
Management of patients with septic shock due to Candida infection 84
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains 83
Antifungal stewardship in a tertiary-care institution: a bedside intervention 83
New antibiotics for ventilator-associated pneumonia 83
Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review 83
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia 83
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study 83
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 82
Isavuconazole shortens the QTc interval 82
Emerging treatment options for acute bacterial skin and skin structure infections: Focus on intravenous delafloxacin 82
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 81
Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19” 80
Reuse of clinical COVID-19 patient data: Pre-processing for future classification 80
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 79
How to manage Pseudomonas aeruginosa infections 79
How much European prescribing physicians know about invasive fungal infections management? 78
Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance 78
Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant/ extensively drug-resistant/pandrug-resistant bacteria 76
The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm 75
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 74
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey (Infection, (2024), 52, 3, (1125-1141), 10.1007/s15010-023-02169-7) 74
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 73
Early diagnosis of candidemia with explainable machine learning on automatically extracted laboratory and microbiological data: results of the AUTO-CAND project 73
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 72
Antifungal stewardship in daily practice and health economic implications 72
Rational approach in the management of Pseudomonas aeruginosa infections 72
Early versus late intubation in COVID-19 patients failing helmet CPAP: A quantitative computed tomography study 71
Amoebic Liver Abscess: Potential Application of New Diagnostic Techniques for an Old Pathogen 70
Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges? 70
An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old 69
Totale 11.048
Categoria #
all - tutte 67.970
article - articoli 67.970
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021215 0 0 0 0 0 0 0 0 0 98 70 47
2021/2022963 37 28 37 63 48 40 48 168 184 94 58 158
2022/20231.499 117 135 15 134 170 154 80 96 240 122 183 53
2023/20241.366 56 108 35 172 139 215 125 128 65 50 89 184
2024/20253.893 105 281 103 225 496 425 369 586 173 217 379 534
2025/20266.408 827 250 607 546 762 452 1.038 504 720 702 0 0
Totale 15.447